MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0077927
Apionex Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹17.29 Cr
▲ 5% YoY
Net profit · FY 2024
₹65.51 Lakh
Net margin 3.8%
EBITDA · FY 2024
₹97.26 Lakh
EBITDA margin 5.6%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹3.93 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
About Apionex Pharma Private Limited
Data last updated:
Apionex Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 05 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33209MH2018PTC315329. Its GSTIN is 27AARCA4261F1ZK (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Nirav Vinod Shah and Nikita Nirav Shah (Director Appointed In Casual Vacancy).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1206 Plot No 856 Ghanshyam Enclave Link Road Lalji Pada Kandivali (West), Mumbai, Maharashtra, India – 400067.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.29 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹65.51 Lakh (net margin 3.8%) and EBITDA of ₹97.26 Lakh (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 236% over five years.
The company is associated with 1 brand: Apionex. As per MCA filings, the company has open charges of ₹3.93 Cr on record.
Apionex Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0077927). For more details, the company can be reached via its website apionex.com.
Company details
CIN U33209MH2018PTC315329
Registration Number 315329
Incorporation Date 05 October 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-MH-18-0077927
Key People
Nirav Vinod Shah Director Nikita Nirav Shah Director Appointed In Casual Vacancy Chintal Tejas Laliwala Additional Director Recognitions & Rankings of Apionex Pharma
Contact details
Apionex Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is apionex.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1206 Plot No 856 Ghanshyam Enclave Link Road Lalji Pada Kandivali (West), Mumbai, Maharashtra, India – 400067
- IndustryPharma, API Manufacturers
To see the full contact details of Apionex Pharma Private Limited, buy the company report.
Comprehensive company report
Apionex Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Apionex Pharma operates one associated brand: Apionex. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of active pharmaceutical ingredients and contract-based molecule development services. | apionex.com |
Business activity
The main business activity of Apionex Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Apionex Pharma Private Limited, buy the company report.
Financials of Apionex Pharma Private Limited
FY 2025 filings availableApionex Pharma Private Limited reported revenue of ₹17.29 Cr (up 5% YoY) for FY 2024.
Revenue · FY 2024
₹17.29 Cr ▲ 5%
Net profit · FY 2024
₹65.51 Lakh margin 3.8%
EBITDA · FY 2024
₹97.26 Lakh margin 5.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 31%
5 years · compounded
▲ 236%
EBITDA CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 38%
5 years · compounded
▲ 77%
Revenue has grown at a compounded annual rate (CAGR) of 236% over five years, including 5% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹97.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹65.51 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 3.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apionex Pharma Private Limited, buy the company report.
Board of directors of Apionex Pharma Private Limited
Apionex Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirav Vinod Shah Also directs: Enolic Pharma Private Limited | Director | 05 Oct 2018 | 8 Years 1 Months | Current |
| Nikita Nirav Shah Also directs: Enolic Pharma Private Limited | Director Appointed In Casual Vacancy | 09 Dec 2024 | 1 Years 11 Months | Current |
| Chintal Tejas Laliwala | Additional Director | 11 Dec 2024 | 1 Years 10 Months | Current |
Peer comparison
Apionex Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sami Nutraceuticals Private Limited | ₹18 Cr (FY 2025) | 0.0% | Bengaluru, Karnataka, India | |||
| Maksons Fine Chem Private Limited | ₹17.53 Cr (FY 2024) | -4.0% | Ankleshwar, Gujarat, India | |||
| Shriya Chemicals Pvt Ltd | ₹17.35 Cr (FY 2015) | -29.0% | Navi Mumbai, Maharashtra, India | |||
| Apionex Pharma Private Limitedthis company | ₹17.29 Cr (FY 2024) | ₹65.51 Lakh | 3.8% | 5.0% | Mumbai, Maharashtra, India | |
| Sreepathi Lab Private Limited | ₹17.28 Cr (FY 2024) | 0.0% | Nalgonda, Telangana, India | |||
| Rangodadhi Chemicals Private Limited | ₹17.2 Cr (FY 2025) | -18.0% | Ahmedabad, Gujarat, India | |||
| Three A Chemie Private Limited | ₹17.19 Cr (FY 2024) | -50.0% | ||||
| Hermes Laboratories Private Limited | ₹17.16 Cr (FY 2024) | 7.0% | Doddaballapur, Karnataka, India |
To see the full peer comparison of Apionex Pharma Private Limited, buy the company report.
Auditor
Apionex Pharma Private Limited is audited by NIRAJ SANGHAVI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NIRAJ SANGHAVI & ASSOCIATES | FY 2023 | F143341W |
Shareholding
The shareholding of Apionex Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Apionex Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.93 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 May 2025 | 101097517 | Hdfc Bank Limited | ₹18 Lakh | Open | |
| 29 Jan 2022 | 100534981 | Hdfc Bank Limited | ₹3.75 Cr | Open |
To see the full charge records of Apionex Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Apionex Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apionex Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Apionex Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARCA4261F1ZK | Maharashtra | Active | 13 Dec 2018 |
| 24AARCA4261F1ZQ | Gujarat | Active | 21 May 2019 |
To see the full GST registrations and return filing status of Apionex Pharma Private Limited, buy the company report.
Recent activity
Apionex Pharma Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Chintal Tejas Laliwala was appointed as Additional Director on 11 Dec 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 375.00 Lakh registered on 29 Jan 2022 with Charge ID 100534981 was modified on 31 Jan 2026.
AGM
Apionex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 18.00 Lakh with Charge ID 101097517 was registered on 03 May 2025.
Filing
Apionex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Chintal Tejas Laliwala was appointed as Additional Director.
Appointed
Nikita Nirav Shah was appointed as Director Appointed In Casual Vacancy.
Ceased
Pratik Mohan Agnihotri ceased to be Director.
Ceased
Akash Mishra ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 375.00 Lakh with Charge ID 100534981 was registered on 29 Jan 2022.
Appointed
Nirav Vinod Shah was appointed as Director.
Incorporation
05 Oct 2018
Apionex Pharma Private Limited was registered on 05 Oct 2018 with Roc Mumbai I & aged 8 years 1 month as per MCA records.
Frequently asked questions
Apionex Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 05 October 2018 (8+ years old) and is registered under CIN U33209MH2018PTC315329.
Apionex Pharma has 3 current directors:
- Nirav Vinod Shah - Director
- Nikita Nirav Shah - Director Appointed In Casual Vacancy
- Chintal Tejas Laliwala - Additional Director
The latest financial statements of Apionex Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Apionex Pharma is 27AARCA4261F1ZK, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AARCA4261F1ZQ (Gujarat).
The CIN (Corporate Identification Number) of Apionex Pharma is U33209MH2018PTC315329. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apionex Pharma was incorporated on 05 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Apionex Pharma by revenue are Sami Nutraceuticals Private Limited, Maksons Fine Chem Private Limited, Shriya Chemicals Pvt Ltd, Sreepathi Lab Private Limited, Rangodadhi Chemicals Private Limited and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chintal Tejas Laliwala was appointed as Additional Director on 11 Dec 2024. Nikita Nirav Shah was appointed as Director Appointed In Casual Vacancy on 09 Dec 2024. Pratik Mohan Agnihotri ceased to be Director on 10 Nov 2024. Apionex Pharma has 5 board changes on record in total.
Yes, Apionex Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0077927).
Apionex Pharma can be reached through the website apionex.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Apionex Pharma is at 1206 Plot No 856 Ghanshyam Enclave Link Road Lalji Pada Kandivali West, Mumbai, Maharashtra, India – 400067.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages